Apimeds Pharmaceuticals US

APUSNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$6.384 M

$4.23 -12.42%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$6.00M

Loss-making

Shares outstanding

15,091,177

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#457Alzamend NeuroALZN$6.56M
#458FibroBiologicsFBLG$6.50M
#459Apimeds Pharmaceuticals USAPUS$6.38M
#460Aptevo TherapeuticsAPVO$6.35M
#461Enveric BiosciencesENVB$6.24M

Where these numbers come from

Share counts and financials for Apimeds Pharmaceuticals US are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.